MT Newswires
Novartis Completes Acquisition of Avidity Biosciences
📈
AI Sentiment
Highly Positive
8/10
Novartis AG News
Latest updates and market news for NVS
20 news
Feb 21 - Feb 27, 2026
Page 1
MT Newswires
Sector Update: Health Care Stocks Lean Lower Pre-Bell Friday
📉
AI Sentiment
Negative
3/10
GlobeNewswire
Novartis successfully completes acquisition of Avidity Biosciences, strengthening late-stage neuroscience pipeline and advancing xRNA strategy
📈
AI Sentiment
Highly Positive
9/10
MT Newswires
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Friday Amid Inflation Data Release
âž–
AI Sentiment
Neutral
4/10
MT Newswires
Novartis Says EMA Panel Recommends Remibrutinib for Chronic Spontaneous Urticaria
âž–
AI Sentiment
Neutral
5/10
GlobeNewswire
Novartis receives positive CHMP opinion for remibrutinib in chronic spontaneous urticaria (CSU)
📈
AI Sentiment
Highly Positive
10/10
BioPharma Dive
Generate caps a strong month for biotech IPOs with $400M offering
📈
AI Sentiment
Highly Positive
9/10
Motley Fool
Stock Market Today, Feb. 25: Novo Nordisk Dips After Announcing $2.1 Billion Partnership With Vivtex for Oral Drug-Delivery Technologies
📉
AI Sentiment
Negative
2/10
MT Newswires
Novartis AG to Build Radioligand Therapy Manufacturing Site in Texas, Expand US network
📊
AI Sentiment
Positive
6/10
Reuters
Novartis to build radioligand therapy site in Texas to expand US manufacturing
📈
AI Sentiment
Highly Positive
8/10
Pharmaceutical Technology
Slate Medicines raises $130m in funds to progress anti-PACAP treatments
📈
AI Sentiment
Highly Positive
8/10
GlobeNewswire
Novartis to build new radioligand therapy site in Denton, Texas, delivering more next‑generation treatments to patients
📈
AI Sentiment
Highly Positive
9/10
GlobeNewswire
Novartis AG Enterprise Technology Report 2025: Digital Transformation Strategies, Innovation Programs, Technology Initiatives, Partnerships, Investment & Acquisition, Network Map
📈
AI Sentiment
Highly Positive
9/10
Simply Wall St.
Assessing Novartis (SWX:NOVN) Valuation After Positive Phase III Data And Upcoming Regulatory Milestones
📈
AI Sentiment
Highly Positive
8/10
Motley Fool
Could Novartis Stock Quietly Help You Build a Millionaire Retirement Portfolio?
📊
AI Sentiment
Positive
7/10
GlobeNewswire
New real‑world data reinforce earlier use of Pluvicto™ before chemotherapy in metastatic castration-resistant prostate cancer
📈
AI Sentiment
Highly Positive
9/10
Motley Fool
Stock Market Today, Feb. 23: Novo Nordisk Plunges 16% After Obesity Drug Falls Short
📉
AI Sentiment
Negative
2/10
Zacks
What's in Store for These 5 Medical Companies This Earnings Season?
📊
AI Sentiment
Positive
7/10
Share this news page